TABLE 1.
Demographic and Treatment Characteristics of HL Survivors
| Patient Characteristic | Total (n = 31) n (%) |
Radiotherapy Only (n = 13) n (%) |
Multimodal Therapy (n = 18) n (%) |
|---|---|---|---|
| Sex | |||
| Male | 12 (39) | 5 (39) | 7 (39) |
| Female | 19 (61) | 8 (62) | 11 (61) |
| Age, y | |||
| 25–34 | 1 (3) | 0 (0) | 1 (6) |
| 35–44 | 25 (81) | 9 (69) | 16 (89) |
| 45–55 | 5 (16) | 4 (31) | 1 (6) |
| Age at cancer diagnosis, y | |||
| 0–9 | 6 (22) | 4 (36) | 2 (11) |
| 10–14 | 6 (19) | 4 (29) | 2 (11) |
| 15–19 | 19 (59) | 5 (36) | 14 (78) |
| Years since diagnosis | |||
| 15–24 | 18 (58) | 3 (23) | 15 (83) |
| 25–34 | 8 (26) | 5 (39) | 3 (17) |
| 35–39 | 5 (16) | 5 (38) | 0 (0) |
| Race/ethnicity | |||
| Non-Hispanic white | 26 (84) | 12 (92) | 14 (78) |
| Non-Hispanic black | 5 (16) | 1 (8) | 4 (22) |
| Treatment | |||
| Anthracycline exposure | |||
| <150 mg/m2 | 6 (33) | NA | 6 (33) |
| 150–249 mg/m2 | 9 (50) | NA | 9 (50) |
| ≥250 mg/m2 | 3 (17) | NA | 3 (17) |
| Chest radiotherapy | |||
| <20 Gy | 3 (10) | 0 (0) | 3 (17) |
| 20–29 Gy | 13 (42) | 0 (0) | 13 (72) |
| ≥30 Gy | 15 (48) | 13 (100) | 2 (11) |
| Cardiovascular risk factors | |||
| Overweight (BMI 25–29) | 13 (42) | 5 (39) | 7 (39) |
| Obesity (BMI ≥30) | 5 (16) | 1 (8) | 4 (22) |
| Diabetes mellitus | 1 (3) | 0 (0) | 1 (6) |
| Hypertension | 7 (23) | 2 (15) | 5 (28) |
| Dyslipidemia | 15 (48) | 6 (46) | 9 (50) |
| Smoker | |||
| Current | 6 (19) | 3 (23) | 3 (17) |
| Past | 7 (23) | 3 (23) | 4 (22) |
| Never | 18 (58) | 7 (54) | 11 (61) |
Abbreviations: BMI, body mass index; HL, Hodgkin lymphoma.